Hitachi High-Technologies Introduces New Regulus Series of Field-Emission Scanning Electron Microscopes

– High-Quality Imaging with Improved Resolution, Higher Magnification, and New Functions – Tokyo, Japan, May 29, 2017 – Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) announced the introduction of the new Regulus series of field emission scanning electron microscopes (FE-SEM) on May 30. As a new brand for FE-SEMs, the Regulus series lineup comprises four... Read more

Featuring High Sensitivity, High Speeds, Multi-Functionality, and Compatibility with Integrated Data Managementwith Other InstrumentsRelease of Three Semi-Micro Analytical Balances

Shimadzu announces the addition of three high-sensitivity semi-micro analytical balances to its AP-W series lineup. The new models, AP135W, AP125WD, and AP225WD, feature a minimum reading of 0.01 mg (1/100000th of a gram). These new models take approximately two seconds to obtain a final measurement reading, enabling high-speed measurement. They are also equipped with a... Read more

SCIEX Announces the First FDA-Cleared Vitamin D Assay Kit for Mass Spectrometry

SCIEX Vitamin D 200M Assay for the TopazTM System designed to measure Vitamin D with greater accuracy and simplicity for In Vitro Diagnostic (IVD) analysis in clinical diagnostic labs May 24, 2017 Framingham, MA — SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry,... Read more

New On-Demand Targeted Next-Generation Sequencing Panels for Inherited Disease Research Deliver User Customization Without High Upfront Cost

Clinical researchers studying germline disorders now have access to an extension of the highly referenced, Ion AmpliSeq next-generation sequencing (NGS) line of assays. The new Ion AmpliSeq On-Demand targeted sequencing panels for inherited disease research provide easy and practical design customization capabilities to lower upfront costs regardless of project size. Thermo Fisher Scientific will introduce... Read more

New data at ATS add to the body of evidence for Roche’s Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF)

Basel, 24 May 2017 New data at ATS add to the body of evidence for Roche’s Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF) In new post hoc analyses of phase III data, Esbriet reduced the risk of death in patients with more advanced lung function impairment and the risk of respiratory-related hospitalisations as a first... Read more

New data at ATS add to the body of evidence for Roche’s Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF)

Basel, 24 May 2017 New data at ATS add to the body of evidence for Roche’s Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF) In new post hoc analyses of phase III data, Esbriet reduced the risk of death in patients with more advanced lung function impairment and the risk of respiratory-related hospitalisations as a first... Read more

FlowJo, LLC Launches Cloud Platform for Multi-omics Experiments

New platform enables real-time collaboration for scientific workflows May 23, 2017 09:00 AM Eastern Daylight Time ASHLAND, Ore. & BOSTON–(BUSINESS WIRE)–FlowJo, LLC, a life science informatics and data analysis company with 19+ years experience in software for analyzing single-cell data, launched FlowJo Envoy, a cloud environment for the coordination of the resources, people, and data... Read more

Lab7 Systems Announces High-Performance Cloud for Genomic-Scale Data Management Built on IBM Cloud

Purpose-built hybrid cloud improves performance and reduces cost of genomic analysis and data management May 23, 2017 06:00 AM Pacific Daylight Time AUSTIN, Texas–(BUSINESS WIRE)–Lab7 Systems, Inc., a leader in laboratory workflow management for data-intensive life science applications, announces the Lab7 High-Performance Genomic Cloud powered by IBM, a complete solution for the management and analysis... Read more